Format

Send to

Choose Destination
Endocrinology. 2015 Apr;156(4):1504-13. doi: 10.1210/en.2014-1738. Epub 2015 Jan 15.

Maternal adiponectin controls milk composition to prevent neonatal inflammation.

Author information

1
Department of Pharmacology (Z.J., Y.D., Y.W.), Touchstone Diabetes Center and Department of Internal Medicine (I.W.A., P.E.S.), The University of Texas Southwestern Medical Center, Dallas, Texas 75390; and Department of Chemistry and Chemical Biology (A.G.S., A.S.), Harvard University, Cambridge, Massachusetts 02138.

Abstract

Adiponectin is an important adipokine. Increasing evidence suggests that altered adiponectin levels are linked with metabolic and inflammatory disorders. Here we report an important yet previously unrecognized function of adiponectin in lactation by which maternal adiponectin determines the inflammatory status in the nursing neonates. Surprisingly, both maternal adiponectin overexpression in the transgenic mice and maternal adiponectin deletion in the knockout mice lead to systemic inflammation in the pups, manifested as transient hair loss. However, distinct mechanisms are involved. Adiponectin deficiency triggers leukocyte infiltration and production of inflammatory cytokines in the lactating mammary gland. In contrast, adiponectin overabundance increases lipid accumulation in the lactating mammary gland, resulting in excessive long-chain saturated fatty acids in milk. Interestingly, in both cases, the inflammation and alopecia in the pups can be rescued by Toll-like receptor (TLR)-2/4 deletion because TLR2/4 double-knockout pups are resistant. Mechanistically, long-chain saturated fatty acid activation of inflammatory genes is TLR2/4 dependent and can be potentiated by proinflammatory cytokines, indicating that the inflammatory stimuli in both scenarios functionally converge by activating the TLR2/4 signaling. Therefore, our findings reveal adiponectin as a dosage-dependent regulator of lactation homeostasis and milk quality that critically controls inflammation in the nursing neonates. Furthermore, these results suggest that inflammatory infantile disorders may result from maternal adiponectin dysregulation that can be treated by TLR2/4 inhibition.

PMID:
25590242
PMCID:
PMC4399311
DOI:
10.1210/en.2014-1738
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center